Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression - Wikidata - wikimedia - TriplyDB

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression

http://www.wikidata.org/entity/Q28284354

about

ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy APOE genotype and stress response - a mini review Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions In vivo human apolipoprotein E isoform fractional turnover rates in the CNS The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging.HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles Anti-infective activity of apolipoprotein domain derived peptides in vitro: identification of novel antimicrobial peptides related to apolipoprotein B with anti-HIV activity Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism HIV-associated neurocognitive disorder.Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits Host genetic factors predisposing to HIV-associated neurocognitive disorder.HIV infection, inflammation, immunosenescence, and aging.The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.Loss of motor function in preclinical Alzheimer's disease Cross-talk between apolipoprotein E and cytokines Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months.APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Novel mechanisms of central nervous system damage in HIV infection.Editorial neuroAIDS review.Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.Cognitive and Everyday Functioning in Older and Younger Adults with and without HIV.Human apolipoprotein E genotypes differentially modify house dust mite-induced airway disease in mice Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity.Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.APOE genotype affects the pre-synaptic compartment of glutamatergic nerve terminals

P2860

Q24312075-99EE6CF9-7423-4E33-B33F-32117E9855CD Q24604376-30D353F2-B8F3-4ACD-A019-A3D88ABC5454 Q26741633-14DD8943-4FAB-49E1-A68A-3B4AAD5F701C Q26781578-3FB69FDB-59A2-4EDA-A55C-0EDA53E0A603 Q26865707-FC89C7A9-A6AC-494C-A324-EDBA6A51F7F3 Q27491003-D2AD113D-DA2D-4B9B-A40E-94EF34D3AA11 Q27672294-0FAD0D97-2582-4B6B-A54A-96514070FA17 Q28728902-3794D988-DACD-418E-BF25-0AF49B4F634E Q28729004-2D5BDFA6-C250-4ABA-95C2-4763F1035A87 Q30410418-B6ABF2B4-1605-4C1A-8446-CFAA8FC34158 Q30421643-B89E7587-1333-4868-B57C-A35337F55185 Q30462497-585918E5-3787-4682-BFF8-EE1F1818432A Q33382373-A8128021-247E-48D5-8E5A-9129057A0485 Q33542839-2899247C-1000-4089-BE15-6A9454AEC933 Q33813945-8EDDDBB7-9383-4EE0-945A-7CD6E1B0445C Q33920647-8F371182-6B23-44BD-BFC5-6CA061FBF470 Q33933106-66333ED2-A875-4227-A856-9FC2996B8CB9 Q33939729-86D3A084-0319-4FF6-BFB6-1FC20D42F63C Q33961790-CAED8EF1-EEB1-4025-A4B9-84AFA1DBCD23 Q34001122-20182DEC-2C08-40C1-B553-4F15011E4323 Q34150710-9D3FDFE1-A127-45C1-804F-0068AA9F9EE0 Q34190545-8E6F91C8-A0B4-4FD8-B6A0-F27CAC8F70CE Q34714286-DCA39E84-D393-4030-B73A-B19EBDAD0481 Q35058529-232EDC71-0EF8-4393-9BE7-7167A9D62094 Q35064701-1A674D9F-3443-4E32-903C-BB0A9E27711B Q35104765-2AA80676-92EC-42A2-8C3C-C0E75DE45AA3 Q35127516-BDFE83B7-9343-4F10-AD4D-13A14D90A049 Q35231766-5D4E335A-C8D4-479F-A2B1-2751D4B35335 Q35276365-AE68F227-CF67-494C-884F-68D3819BBC4A Q35276630-54DD3359-74D8-46DA-9AEA-0CA4222DDC37 Q35557261-1B7AC9EC-05ED-411B-AD39-15B01F21B02D Q35731648-8963E76F-01D4-4E72-A7DB-579ECD0E46B5 Q35815986-BA4AE7E6-9BA4-46B5-8369-1763E2D13A55 Q35929537-8CB5270D-AE0A-4AE1-BA79-E1CC8B000933 Q35950145-B7C3A1A3-2ED6-40B9-A7D3-49D8475F86B2 Q36162221-C493982B-D37B-4EB0-9305-6FFA2DB3B94A Q36318703-F95784C0-3734-4F26-8CD3-921A5136F317 Q36376727-207E7B43-1BB5-4263-A24E-C025023532B6 Q36429120-10EFD5C6-0A52-4AC7-B06C-EE954CFFC8D1 Q36431326-6659A4BC-3852-454B-8E13-3AE38DB01AD1

P2860

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression

http://www.wikidata.org/entity/Q28284354

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@ast

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@en

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@nl

type

label

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@ast

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@en

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@nl

prefLabel

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@ast

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@en

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@nl

P1433

Q28284354-4CB4B4BD-7D60-4C85-8165-F24B7EFEC7CA

P1476

Q28284354-030A0C39-DDDF-45FF-A13E-0274B00B0D3C

P2093

Q28284354-00810F49-131A-41DC-A954-1AC00C6634A7

Q28284354-64DBBD3A-DED8-4E9E-91ED-E6DEA29CB6C3

Q28284354-90545485-4614-4B1D-95A1-42848A89E28D

Q28284354-97AD5A73-CDAE-4C16-8D04-FF5500E79AEF

Q28284354-9A9E67EB-9B3C-4314-8633-7C142B4C2A37

Q28284354-D9081586-00EA-47D0-9B21-C2962B7644AE

Q28284354-DD03B0A8-86B9-431A-A4B7-F81AD1A47EDE

Q28284354-E8F9A5AB-8689-4E8A-8D19-AE668C37FF8B

Q28284354-EFBD7288-EA51-4FA0-9CF5-E550EB5DF361

P2860

Q28284354-014A2314-ADC4-4745-8FB5-BD296D9760B2

Q28284354-03AFB0FD-6359-4EC2-8DDD-A82606F6E864

Q28284354-0510774B-5822-4333-BAC5-309F8327A8F0

Q28284354-0E558A3C-BA9A-4CA8-B657-82615475D234

Q28284354-168EA575-802A-45B3-B72F-36A5BCB452D9

Q28284354-20854202-D887-4214-991E-1EBB171F5E34

Q28284354-2277C1E2-BA1C-4F38-BB3A-758FE5DB52B6

Q28284354-25B36EF7-9756-4CE5-993D-1720DF3D1DB8

Q28284354-29272FE1-B8D8-443A-9FBB-1BDBFB91B9C0

Q28284354-34D93413-A606-4335-A2D5-55E101014E35

P304

Q28284354-3D94D380-427A-45F9-BB13-CD8B33436D44

P31

Q28284354-A0E15EC1-6778-4523-956A-BFE1631A3458

P3181

Q28284354-5C76BC36-035D-4D95-B49B-37FF5B6553C2

P356

Q28284354-36ABA577-8526-4487-9739-57296254F2D5

P407

Q28284354-493FBC1D-F975-412E-95C8-2FF4BF77E5DF

P433

Q28284354-ACA720AE-139E-4C7B-BE7F-AAA010F86FC5

P478

Q28284354-798D5219-1142-4B56-9544-CF8F7A4011D3

P50

Q28284354-2AA81796-4EBF-4473-95E2-7FC0BBA8DFDF

Q28284354-574BD99A-A678-4EE7-86FB-2BAAC0B30927

Q28284354-6783B340-0B27-4464-BCCC-6955BD3CC289

P577

Q28284354-ACB39598-1AC5-4FCD-A6FD-CAA277DBEA44

P5875

Q28284354-508CBDB1-175E-4701-91B8-50E19F371C38

P698

Q28284354-C1E0F4FF-0AB8-4AF0-B47B-AEDEA63DD74E

P921

Q28284354-3A7774F8-C9F4-40CD-8866-21DCC2E0FB54

P932

Q28284354-040F168C-07FD-4652-96EF-46C71C9DA039

P3181

P356

PNAS.0803526105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Apolipoprotein (apo) E4 enhanc ...... erates HIV disease progression

@en

P2093

Hemant Kulkarni

http://www.w3.org/2001/XMLSchema#string

Joseph M McCune

http://www.w3.org/2001/XMLSchema#string

Marielle Cavrois

http://www.w3.org/2001/XMLSchema#string

Matthew J Dolan

http://www.w3.org/2001/XMLSchema#string

Robert W Mahley

http://www.w3.org/2001/XMLSchema#string

Sunil K Ahuja

http://www.w3.org/2001/XMLSchema#string

Trevor D Burt

http://www.w3.org/2001/XMLSchema#string

Weijing He

http://www.w3.org/2001/XMLSchema#string

Yadong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

CCR5 deficiency increases risk of symptomatic West Nile virus infection

Apolipoprotein 3 allele is associated with persistent hepatitis C virus infection

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Apolipoprotein E: far more than a lipid transport protein

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

HIV entry inhibitors: mechanisms of action and resistance pathways

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

P304

8718-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4423498

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0803526105

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Vincent C Marconi

P577

2008-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242908727

http://www.w3.org/2001/XMLSchema#string

P698

18562290

http://www.w3.org/2001/XMLSchema#string

P921

P932

2438419

http://www.w3.org/2001/XMLSchema#string